ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 294526 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 294526; 2) Community: the network communities that were significantly associated with the response to NSC 294526; 3) Molecule: the relationships between components within communities and NSC 294526; 4) MDR: the compounds that were significantly associated with the NSC 294526.

NSC Compound Enrichment Correlation
NSC 743430 2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0430277102950697 -0.05612032
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.0430277102950697 0.29102446
NSC 756350 GW784752X 0.0430277102950697 -0.045600875
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0430277102950697 0.35735457
NSC 87086 Null 0.0430277102950697 -0.20620731
NSC 759877 Dasatinib (USAN) 0.04302771029507 -0.12247631
NSC 630375 2H-1-Benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- 0.0454469012959163 -0.2597526
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0454469012959163 0.54168296
NSC 641111 Null 0.0454469012959163 0.44558156
NSC 650792 1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- 0.0454469012959163 -0.32553086
Total:114  Current:110    [First] [Prev] [Next] [Last]